Neurovascular devices (such as coils) aid in treatment of various neurovascular disorders such as cerebral aneurysms and intracranial atherosclerotic disease. Rise in geriatric population and upsurge in number of patients suffering from neurovascular disorders are expected to drive the market growth. Moreover, increase in adoption of new minimally invasive techniques such as flow diversion and carotid artery stenting boosts the market growth. However, high cost of the devices and dearth of neurosurgeons are expected to impede the market growth.
As per the estimates of the Centers for Disease Control and Prevention, more than 795,000 people in the U.S. suffer from stroke every year. In addition, rise in geriatric population poses risk for increase in incidence of neurovascular disorders (such as stroke). For instance, according to The Internet Stroke Center, nearly 75% of strokes occur in people over the age of 65. Moreover, the risk of having a stroke doubles after the age of 55.
Get Exclusive Sample Report @ https://dataintelo.com/request-sample/?reportId=714
The Report entitled 2019-2026 Global Neurovascular Devices Market Report explores the essential factors of the Neurovascular Devices market considering such as industry situations, market demands, market players adopted business strategies and their growth scenario. The Global Neurovascular Devices market has been separated by this report based on the key players profiles, Type, Application and Regions.
The global Neurovascular Devices Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2021-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the neurovascular devices market include Heat Map Analysis of Private Companies, Abbott, W. L. Gore & Associates, Inc., Johnson & Johnson, Medtronic, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Stryker and Terumo Medical Corporation.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Neurovascular Devices Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/neurovascular-devices-market/download-sampleMarket DynamicsThe prominent drivers driving the development of the market is the thriving prevalence of strokes across the world.
The other major factors propelling the growth include a swelling number of patients, continuous product improvement, favorable medical compensation, and rising market demand for productive neurovascular devices.
Further, increasing researches for the improvement in neurovascular treatments, along with the expanding awareness among surgeons regarding minimally intrusive surgical methods deliver considerable growth chances in the market.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.
Neurovascular devices are increasingly being used in for treating and management of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm.
As the global burden of neurovascular disorders continue to rise, the demand for their treatments gains further traction.
Other factors that are reflecting favourably on the market include expansion of the geriatric population, and advances in medical technology in the field of interventional neurology.
Owing the low risk of damaging surrounding tissues and minimal surgical trauma, interventional procedure are more favoured as compared to neurosurgery.
On the other hand, inadequate number of hilly skilled neurologist, particularly in developing countries expected to have a negative impact on the growth of the market.
Reportedly, the funding syndicate in included two new international investors with the existing stakeholders.
